Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-17-000049
Filing Date
2017-06-30
Accepted
2017-06-30 17:26:58
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K cantabio_10k.htm 10-K 585331
2 EXHIBIT 31 ex_31_1.htm EX-31.1 16299
3 EXHIBIT 32 ex_31_2.htm EX-31.2 15691
4 EXHIBIT 32.1 ex_32_1.htm EX-32.1 5621
5 EXHIBIT 32.2 ex_32_2.htm EX-32.2 5808
  Complete submission text file 0001424884-17-000049.txt   1993378

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctbo-20170331.xml EX-101.INS 210166
7 XBRL TAXONOMY EXTENSION SCHEMA ctbo-20170331.xsd EX-101.SCH 30283
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctbo-20170331_cal.xml EX-101.CAL 11992
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctbo-20170331_def.xml EX-101.DEF 65056
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctbo-20170331_lab.xml EX-101.LAB 131098
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctbo-20170331_pre.xml EX-101.PRE 130098
Mailing Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-54906 | Film No.: 17943223
SIC: 2834 Pharmaceutical Preparations